Overview

Effect of BMS-986165 on the Blood Levels of Metformin

Status:
Completed
Trial end date:
2021-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of BMS-986165 on the drug levels of metformin in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
BMS-986165
Metformin